Aytu BioScience, Inc. (NASDAQ:AYTU) Commercial Portfolio Acquisition Overview Conference Call October 14, 2019 4:30 PM ET Company Participants Josh Disbrow - Chairman and Chief Executive Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Carl Byrnes - Northland Capital Markets Operator Good afternoon, everyone, and thank you for joining us for this Conference Call discussing Aytu BioScience’s Announced Acquisition of a Six Product Commercial Portfolio. With me this afternoon to discuss ...